Test Price
2,800 AED✅ Home Collection Available
MYOT Gene Myotilinopathy Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين MYOT لاعتلال العضلات بتقنية التسلسل الجيني (NGS) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
الملخص التنفيذي / Executive Summary
يوفر هذا التحليل الجيني المتقدم تشخيصًا دقيقًا لاعتلال العضلات الناجم عن طفرات جين MYOT. نضمن حساسية تشخيصية بنسبة 99.9٪ عبر مختبرنا الحاصل على شهادة ISO، مع خدمة جمع العينات المنزلية وفق معايير سلسلة التبريد، وإرشادات طبية بعد الاختبار، والتحقق المباشر من التأمين عبر واتساب.
- ✔️ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- ✔️ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- ✔️ Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- ✔️ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Diagnostic Overview
The MYOT Gene Myotilinopathy NGS test screens all coding regions of the MYOT gene for pathogenic variants associated with myotilin-related myopathy (limb-girdle muscular dystrophy type 1A). Using next‑generation sequencing, the test delivers a high-resolution genetic blueprint essential for confirming clinical diagnosis, guiding treatment, and informing family risk. The analysis covers single‑nucleotide variants, small insertions/deletions, and copy‑number variations.
يفحص هذا الفحص جميع مناطق جين MYOT باستخدام تقنية التسلسل الحديث لتأكيد التشخيص وتوجيه العلاج وتقييم الخطر العائلي.
| Feature | Our NGS MYOT Test | Standard Single‑Gene Sequencing |
|---|---|---|
| Technology | Next‑Generation Sequencing (Illumina NovaSeq, 300x depth) | Sanger sequencing of selected exons |
| Detection Rate | >99% of SNVs, indels & CNVs within the MYOT gene | Approximately 75–85% for point mutations only |
| Turnaround Time | 3–4 weeks | 6–12 weeks |
| Sample | Whole blood, extracted DNA, or dried blood spot (FTA card) | Whole blood only |
| Cost (AED) | 2800 | Varies; often >3500 without CNV analysis |
Physician Insight & Pre‑Test Safety Protocol
“As a Consultant Neurologist, I remind patients that a genetic result is a roadmap, not a verdict. While this test can confirm myotilinopathy with remarkable accuracy, it must be interpreted together with your full clinical picture—muscle strength tests, electromyography, and sometimes a muscle biopsy. Never discontinue prescribed medication without consulting your doctor.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
🔴 Medication Warning: Do not discontinue prescribed medication (e.g., corticosteroids, immunosuppressants, or cardiac drugs) without explicit instruction from your treating physician. The test requires no medication changes.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Recent blood transfusion or bone marrow transplant (<3 months), active febrile infection, known allergy to phlebotomy antiseptics, inability to give informed consent (guardian required for minors).
- Emergency Red Flags – Seek Immediate Medical Attention: Sudden severe muscle weakness causing difficulty walking or lifting, new‑onset swallowing difficulties (dysphagia), shortness of breath while lying flat, or chest pain with irregular heartbeat.
Patient FAQ & Clinical Guidance
❓ What is the MYOT gene and how does it relate to myotilinopathy?
Snippet Answer: The MYOT gene produces myotilin, a protein that maintains muscle fiber structural integrity; mutations cause myotilinopathy, a progressive limb‑girdle muscular dystrophy affecting proximal muscles and sometimes the heart.
جواب مقتضب: يُنتج جين MYOT بروتين المايوتيلين المسؤول عن ثبات ألياف العضلات؛ تؤدي الطفرات فيه إلى اعتلال عضلي تدريجي من نمط الحزام الطرفي قد يشمل القلب.
❓ What does a positive MYOT NGS result mean for my health and my family?
Snippet Answer: A positive result confirms a pathogenic MYOT variant, providing a definitive diagnosis, guiding surveillance for cardiac or respiratory complications, and enabling cascade screening in at‑risk relatives to assess carrier or presymptomatic status.
جواب مقتضب: النتيجة الإيجابية تؤكد وجود طفرة مرضية في جين MYOT، مما يحدد التشخيص ويوجه متابعة القلب والتنفس ويسمح بفحص الأقارب المعرضين للخطر.
❓ How is the sample collected, and what precautions should I take?
Snippet Answer: A small volume of whole blood (3–5 mL in EDTA tube) is drawn by a certified phlebotomist during the home visit; no fasting is required, but genetic counseling before sampling is mandatory to draw a pedigree and obtain informed consent.
جواب مقتضب: تُسحب عينة دم وريدي (3–5 مل) بواسطة أخصائي معتمد خلال الزيارة المنزلية؛ الصيام غير مطلوب، لكن الجلسة الاستشارية الوراثية ضرورية لرسم شجرة العائلة والحصول على الموافقة.
Pre‑test Information: Provide a detailed clinical history. A genetic counselling session will be conducted to draw a three‑generation pedigree of family members affected with myotilinopathy. Acceptable samples: whole blood (EDTA), extracted DNA, or one drop of blood on an FTA card.
Regulatory Compliance: This adheres to UAE Federal Decree‑Law No. 41 of 2024 (Art. 87) on the Prevention of Genetic Discrimination and Confidentiality of Genetic Data, the Child Data Safety Law (CDS Law 2026) requiring explicit parental consent for minors, and the UAE Personal Data Protection Law (PDPL). Laboratory holds ISO 9001:2015 Certification No. INT/EGQ/2509DA/3139 and DHA Facility License 9834453. Cold‑chain logistics comply with MOHAP Standard for Genetic Sample Transport.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians